Effectiveness of Marinomed's antiviral nasal spray confirmed in clinical trial for common cold

Marinomed Biotechnologie GmbH has announced that new clinical data confirmed the effectiveness of a Carragelose®-based nasal spray in the therapy of common cold. The data, generated in collaboration with researchers from the Department of Otolaryngology at the Medical University of Vienna, were published in the international medical journal Respiratory Research.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news